Health Canada approves EGRIFTA Apr 30, 2014 PDF Version Supporting Materials: Health Canada approves EGRIFTA 165.7 KB Montreal, Canada – April 30, 2014 – Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that it has received a notice of compliance (regulatory approval) from Health Canada for EGRIFTA™ (tesamorelin for injection).